Pro-Dex Inc

NASDAQ PDEX

Data sourced from iex and EODHD
Download Data

Pro-Dex Inc Non-Current Liabilities (Other) 1 year YoY Change (%) for the Trailing 12 Months (TTM) ending March 31, 2023: -38.32%

Pro-Dex Inc Non-Current Liabilities (Other) 1 year YoY Change (%) is -38.32% for the Trailing 12 Months (TTM) ending March 31, 2023, a -87.83% change year over year. Non-Current Liabilities (Other) are non-current liabilities that are not classified under long-term debt. The measure "Change (%)" refers to the percentage change in the value of a financial metric between two time points. This measure provides a relative perspective on the magnitude of change.
  • Pro-Dex Inc Non-Current Liabilities (Other) for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 1.75 M.
  • Pro-Dex Inc Non-Current Liabilities (Other) for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 3.73 M, a 17.16% change year over year.
  • Pro-Dex Inc Non-Current Liabilities (Other) for the Trailing 12 Months (TTM) ending March 31, 2020 was USD 3.18 M.
NASDAQ: PDEX

Pro-Dex Inc

CEO Mr. Richard Lee Van Kirk Jr.
IPO Date Aug. 18, 1995
Location United States
Headquarters 2361 McGaw Avenue, Irvine, CA, United States, 92614
Employees 145
Sector Healthcare
Industry Medical instruments & supplies
Description

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

StockViz Staff

September 20, 2024

Any question? Send us an email